Akitada Yogo, Toshihiko Masui, Shigeo Takaishi, Kenji Masuo, Ru Chen, Yosuke Kasai, Kazuyuki Nagai, Takayuki Anazawa, Sadanori Watanabe, Satoko Sakamoto, et al. Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling. Cancer science. 2023. 114. 4. 1324-1336
Atsushi Nonami, Ryu Matsuo, Kouta Funakoshi, Tomohiro Nakayama, Shigenori Goto, Tadafumi Iino, Shigeo Takaishi, Shinichi Mizuno, Koichi Akashi, Masatoshi Eto. Prospective study of adoptive activated αβT lymphocyte immunotherapy for refractory cancers: development and validation of a response scoring system. Cytotherapy. 2023. 25. 1. 76-81
Takaaki Yoshikawa, Akihisa Fukuda, Mayuki Omatsu, Mio Namikawa, Makoto Sono, Yuichi Fukunaga, Tomonori Masuda, Osamu Araki, Munemasa Nagao, Satoshi Ogawa, et al. JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppression. Cancer Science. 2022. 113. 10. 3417-3427
Sadanori Watanabe, Akitada Yogo, Tsuguteru Otsubo, Hiroki Umehara, Jun Oishi, Toru Kodo, Toshihiko Masui, Shigeo Takaishi, Hiroshi Seno, Shinji Uemoto, et al. Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer. BMC cancer. 2022. 22. 1. 489-489
Kenji Masuo, Ru Chen, Akitada Yogo, Aiko Sugiyama, Akihisa Fukuda, Toshihiko Masui, Shinji Uemoto, Hiroshi Seno, Shigeo Takaishi. SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. Cancer Science. 2021. 112. 12. 4987-4999
